SB 497 Health Insurance and Maryland Medical Assistance Program Coverage Opioid Reversal Drugs and Products
Maryland 2024 Regular Session
Health Insurance and Maryland Medical Assistance Program - Coverage - Opioid Reversal Drugs and Products
SB-497
About SB-497
Requiring the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, and health maintenance organizations to cover nonprescription naloxone hydrochloride and any other drug or product that is approved by the federal Food and Drug Administration for the complete or partial reversal of an opioid overdose without imposing a copayment or coinsurance requirement that exceeds $10 per package.
Bill Texts
Introduced 01/24/2024
Weigh In
No votes yet!
Cast yours now to be the first.
Votes for: 0 Votes against: 0
Spread the Word!
Gettr
Sponsors (1)
